Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Equity Ratio (2018 - 2025)

TransMedics has reported Equity Ratio over the past 8 years, most recently at 0.44 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.44 for Q4 2025, up 55.76% from a year ago — trailing twelve months through Dec 2025 was 0.44 (up 55.76% YoY), and the annual figure for FY2025 was 0.44, up 55.76%.
  • Equity Ratio for Q4 2025 was 0.44 at TransMedics, up from 0.38 in the prior quarter.
  • Over the last five years, Equity Ratio for TMDX hit a ceiling of 0.68 in Q3 2022 and a floor of 0.18 in Q3 2023.
  • Median Equity Ratio over the past 5 years was 0.4 (2022), compared with a mean of 0.42.
  • Biggest five-year swings in Equity Ratio: plummeted 73.15% in 2023 and later surged 55.76% in 2025.
  • TransMedics' Equity Ratio stood at 0.5 in 2021, then skyrocketed by 34.4% to 0.68 in 2022, then plummeted by 71.26% to 0.19 in 2023, then skyrocketed by 46.3% to 0.28 in 2024, then soared by 55.76% to 0.44 in 2025.
  • The last three reported values for Equity Ratio were 0.44 (Q4 2025), 0.38 (Q3 2025), and 0.36 (Q2 2025) per Business Quant data.